Obsidio™ Conformable Embolic Registry

NCT06170619 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2026-04-29

No results posted yet for this study

Summary

OCCLUDE is a prospective, post-approval, open-label, single arm, multi-center US registry of patients who undergo embolization with Obsidio™ Conformable Embolic. The purpose of this Registry is to assess effectiveness and safety outcomes of subjects who undergo embolization with Obsidio.

Conditions

Interventions

DEVICE

Obsidio™ Conformable Embolic

Embolization with Obsidio™ Conformable Embolic.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-19
Primary Completion
2025-09-09
Completion
2025-09-09
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06170619 on ClinicalTrials.gov